Tim-3 promotes tumor-promoting M2 macrophage polarization by binding to STAT1 and suppressing the STAT1-miR-155 signaling axis

OncoImmunology

Volumn 5, Issue 9, 2016, Pages

  Jiang, Xingwei ^a,b   Zhou, Tingting ^a   Xiao, Yan ^c   Yu, Jiahui ^d   Dou, Shuaijie ^a   Chen, Guojiang ^a   Wang, Renxi ^a   Xiao, He ^a   Hou, Chunmei ^a   Wang, Wei ^a,d   Shi, Qingzhu ^a   Feng, Jiannan ^a   Ma, Yuanfang ^e   Shen, Beifen ^a   Li, Yan ^a   Han, Gencheng ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d Henan Institute of Population and Family Planning Research   (China)

^e HENAN UNIVERSITY   (China)

Author keywords

Colon cancer; macrophage polarization; miR 155; STAT1; Tim 3

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA; MICRORNA 155; STAT PROTEIN; T CELL IMMUNOGLOBULIN MUCIN PROTEIN 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; COLON CANCER; CONTROLLED STUDY; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; POLARIZATION; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 84983751431     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2016.1211219     Document Type: Article

References (40)

1. K.J.Maloy, F.Powrie. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011; 474:298-306; PMID:21677746; http://dx.doi.org/10.1038/nature10208
2. W.Zhu, J.Yu, Y.Nie, X.Shi, Y.Liu, F.Li, X.L.Zhang. Disequilibrium of M1 and M2 macrophages correlates with the development of experimental inflammatory bowel diseases. Immunol Invest 2014; 43:638-52; PMID:24921428; http://dx.doi.org/10.3109/08820139.2014.909456
3. S.B.Weisser, H.K.Brugger, N.S.Voglmaier, K.W.McLarren, N.van Rooijen, L.M.Sly. SHIP-deficient, alternatively activated macrophages protect mice during DSS-induced colitis. J Leukoc Biol 2011; 90:483-92; PMID:21685246; http://dx.doi.org/10.1189/jlb.0311124
4. M.Yang, J.H.Shao, Y.J.Miao, W.Cui, Y.F.Qi, J.H.Han, X.Lin, J.Du. Tumor cell-activated CARD9 signaling contributes to metastasis-associated macrophage polarization. Cell Death Differ 2014; 21:1290-302; PMID:24722209; http://dx.doi.org/10.1038/cdd.2014.45
5. S.Edin, M.L.Wikberg, A.M.Dahlin, J.Rutegard, A.Oberg, P.A.Oldenborg, R.Palmqvist. The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PloS One 2012; 7:e47045; PMID:23077543; http://dx.doi.org/10.1371/journal.pone.0047045
6. L.C.Davies, S.J.Jenkins, J.E.Allen, P.R.Taylor. Tissue-resident macrophages. Nat Immunol 2013; 14:986-95; PMID:24048120; http://dx.doi.org/10.1038/ni.2705
7. T.A.Wynn, A.Chawla, J.W.Pollard. Macrophage biology in development, homeostasis and disease. Nature 2013; 496:445-55; PMID:23619691; http://dx.doi.org/10.1038/nature12034
8. S.K.Tai, H.C.Chang, K.L.Lan, C.T.Lee, C.Y.Yang, N.J.Chen, T.Y.Chou, D.C.Tarng, S.L.Hsieh. Decoy receptor 3 enhances tumor progression via induction of tumor-associated macrophages. J Immunol 2012; 188:2464-71; PMID:22287720; http://dx.doi.org/10.4049/jimmunol.1101101
9. A.Arranz, C.Doxaki, E.Vergadi, Y.Martinez de la Torre, K.Vaporidi, E.D.Lagoudaki, E.Ieronymaki, A.Androulidaki, M.Venihaki, A.N.Margioris et al. Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc Natl Acad Sci U S A 2012; 109:9517-22; PMID:22647600; http://dx.doi.org/10.1073/pnas.1119038109
10. S.M.Pyonteck, L.Akkari, A.J.Schuhmacher, R.L.Bowman, L.Sevenich, D.F.Quail, O.C.Olson, M.L.Quick, J.T.Huse, V.Teijeiro et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med 2013; 19:1264-72; PMID:24056773; http://dx.doi.org/10.1038/nm.3337
11. T.Lawrence, G.Natoli. Transcriptional regulation of macrophage polarization:enabling diversity with identity. Nat Rev Immunol 2011; 11:750-61; PMID:22025054; http://dx.doi.org/10.1038/nri3088
12. A.Yoshimura, T.Naka, M.Kubo. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007; 7:454-65; PMID:17525754; http://dx.doi.org/10.1038/nri2093
13. X.Cai, Y.Yin, N.Li, D.Zhu, J.Zhang, C.Y.Zhang, K.Zen. Re-polarization of tumor-associated macrophages to pro-inflammatory M1 macrophages by microRNA-155. J Mol Cell Biol 2012; 4:341-3; PMID:22831835; http://dx.doi.org/10.1093/jmcb/mjs044
14. M.Nazari-Jahantigh, Y.Wei, H.Noels, S.Akhtar, Z.Zhou, R.R.Koenen, K.Heyll, F.Gremse, F.Kiessling, J.Grommes et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest 2012; 122:4190-202; PMID:23041630; http://dx.doi.org/10.1172/JCI61716
15. M.L.Squadrito, M.Etzrodt, M.De Palma, M.J.Pittet. MicroRNA-mediated control of macrophages and its implications for cancer. Trends Immunol 2013; 34:350-9; PMID:23498847; http://dx.doi.org/10.1016/j.it.2013.02.003
16. A.Sanchez-Fueyo, J.Tian, D.Picarella, C.Domenig, X.X.Zheng, C.A.Sabatos, N.Manlongat, O.Bender, T.Kamradt, V.K.Kuchroo et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 2003; 4:1093-101; PMID:14556005; http://dx.doi.org/10.1038/ni987
17. W.D.Hastings, D.E.Anderson, N.Kassam, K.Koguchi, E.A.Greenfield, S.C.Kent, X.X.Zheng, T.B.Strom, D.A.Hafler, V.K.Kuchroo. TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur J Immunol 2009; 39:2492-501; PMID:19676072; http://dx.doi.org/10.1002/eji.200939274
18. W.Wu, Y.Shi, S.Li, Y.Zhang, Y.Liu, Y.Wu, Z.Chen. Blockade of Tim-3 signaling restores the virus-specific CD8(+) T-cell response in patients with chronic hepatitis B. Eur J Immunol 2012; 42:1180-91; PMID:22539292; http://dx.doi.org/10.1002/eji.201141852
19. X.Yang, X.Jiang, G.Chen, Y.Xiao, S.Geng, C.Kang, T.Zhou, Y.Li, X.Guo, H.Xiao et al. T cell Ig mucin-3 promotes homeostasis of sepsis by negatively regulating the TLR response. J Immunol 2013; 190:2068-79; PMID:23365080; http://dx.doi.org/10.4049/jimmunol.1202661
20. S.Chiba, M.Baghdadi, H.Akiba, H.Yoshiyama, I.Kinoshita, H.Dosaka-Akita, Y.Fujioka, Y.Ohba, J.V.Gorman, J.D.Colgan et al. Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol 2012; 13:832-42; PMID:22842346; http://dx.doi.org/10.1038/ni.2376
21. V.K.Kuchroo, A.C.Anderson, G.J.Freeman. Comment on “Tim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infection”. J Immunol 2014; 193:467; PMID:24994907; http://dx.doi.org/10.4049/jimmunol.1401123
22. Z.Zhao, X.Jiang, C.Kang, Y.Xiao, C.Hou, J.Yu, R.Wang, H.Xiao, T.Zhou, Z.Wen et al. Blockade of the T cell immunoglobulin and mucin domain protein 3 pathway exacerbates sepsis-induced immune deviation and immunosuppression. Clin Exp Immunol 2014; 178:279-91; PMID:24945079; http://dx.doi.org/10.1111/cei.12401
23. I.Vega-Carrascal, D.A.Bergin, O.J.McElvaney, C.McCarthy, N.Banville, K.Pohl, M.Hirashima, V.K.Kuchroo, E.P.Reeves, N.G.McElvaney. Galectin-9 signaling through TIM-3 is involved in neutrophil-mediated Gram-negative bacterial killing:an effect abrogated within the cystic fibrosis lung. J Immunol 2014; 192:2418-31; PMID:24477913; http://dx.doi.org/10.4049/jimmunol.1300711
24. P.S.van de Weyer, M.Muehlfeit, C.Klose, J.V.Bonventre, G.Walz, E.W.Kuehn. A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9. Biochem Biophy Res Commun 2006; 351:571-6; PMID:17069754; http://dx.doi.org/10.1016/j.bbrc.2006.10.079
25. D.T.Gracias, E.Stelekati, J.L.Hope, A.C.Boesteanu, T.A.Doering, J.Norton, Y.M.Mueller, J.A.Fraietta, E.J.Wherry, M.Turner et al. The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling. Nat Immunol 2013; 14:593-602; PMID:23603793; http://dx.doi.org/10.1038/ni.2576
26. V.Toshchakov, B.W.Jones, P.Y.Perera, K.Thomas, M.J.Cody, S.Zhang, B.R.Williams, J.Major, T.A.Hamilton, M.J.Fenton et al. TLR4, but not TLR2, mediates IFN-β-induced STAT1alpha/β-dependent gene expression in macrophages. Nat Immunol 2002; 3:392-8; PMID:11896392; http://dx.doi.org/10.1038/ni774
27. H.M.Wilson. SOCS Proteins in Macrophage Polarization and Function. Front Immunol 2014; 5:357; PMID:25120543; http://dx.doi.org/10.3389/fimmu.2014.00357
28. X.L.Yan, Y.L.Jia, L.Chen, Q.Zeng, J.N.Zhou, C.J.Fu, H.X.Chen, H.F.Yuan, Z.W.Li, L.Shi et al. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression:role of the S100A4-miR155-SOCS1-MMP9 axis. Hepatology 2013; 57:2274-86; PMID:23316018; http://dx.doi.org/10.1002/hep.26257
29. C.W.Kang, A.Dutta, L.Y.Chang, J.Mahalingam, Y.C.Lin, J.M.Chiang, C.Y.Hsu, C.T.Huang, W.T.Su, Y.Y.Chu et al. Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer. Sci Rep 2015; 5:15659; PMID:26493689; http://dx.doi.org/10.1038/srep15659
30. D.M.Kuang, Q.Zhao, C.Peng, J.Xu, J.P.Zhang, C.Wu, L.Zheng. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J Exp Med 2009; 206:1327-37; PMID:19451266; http://dx.doi.org/10.1084/jem.20082173
31. S.K.Biswas, A.Mantovani. Macrophage plasticity and interaction with lymphocyte subsets:cancer as a paradigm. Nat Immunol 2010; 11:889-96; PMID:20856220; http://dx.doi.org/10.1038/ni.1937
32. B.Z.Qian, J.W.Pollard. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141:39-51; PMID:20371344; http://dx.doi.org/10.1016/j.cell.2010.03.014
33. B.Ruffell, N.I.Affara, L.M.Coussens. Differential macrophage programming in the tumor microenvironment. Trends Immunol 2012; 33:119-26; PMID:22277903; http://dx.doi.org/10.1016/j.it.2011.12.001
34. T.Hagemann, T.Lawrence, I.McNeish, K.A.Charles, H.Kulbe, R.G.Thompson, S.C.Robinson, F.R.Balkwill. “Re-educating” tumor-associated macrophages by targeting NF-kappaB. J Exp Med 2008; 205:1261-8; PMID:18490490; http://dx.doi.org/10.1084/jem.20080108
35. A.Saccani, T.Schioppa, C.Porta, S.K.Biswas, M.Nebuloni, L.Vago, B.Bottazzi, M.P.Colombo, A.Mantovani, A.Sica. p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res 2006; 66:11432-40; PMID:17145890; http://dx.doi.org/10.1158/0008-5472.CAN-06-1867
36. Y.C.Wang, F.He, F.Feng, X.W.Liu, G.Y.Dong, H.Y.Qin, X.B.Hu, M.H.Zheng, L.Liang, L.Feng et al. Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses. Cancer Res 2010; 70:4840-9; PMID:20501839; http://dx.doi.org/10.1158/0008-5472.CAN-10-0269
37. W.Yan, X.Liu, H.Ma, H.Zhang, X.Song, L.Gao, X.Liang, C.Ma. Tim-3 fosters HCC development by enhancing TGF-β-mediated alternative activation of macrophages. Gut 2015; 64:1593-604; PMID:25608525; http://dx.doi.org/10.1136/gutjnl-2014-307671
38. Y.H.Huang, C.Zhu, Y.Kondo, A.C.Anderson, A.Gandhi, A.Russell, S.K.Dougan, B.S.Petersen, E.Melum, T.Pertel et al. CEACAM1 regulates TIM-3-mediated tolerance and exhaustion. Nature 2015; 517:386-90; PMID:25363763; http://dx.doi.org/10.1038/nature13848
39. M.Rangachari, C.Zhu, K.Sakuishi, S.Xiao, J.Karman, A.Chen, M.Angin, A.Wakeham, E.A.Greenfield, R.A.Sobel et al. Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion. Nat Med 2012; 18:1394-400; PMID:22863785; http://dx.doi.org/10.1038/nm.2871
40. Y.Wang, G.Han, K.Wang, G.Liu, R.Wang, H.Xiao, X.Li, C.Hou, B.Shen, R.Guo et al. Tumor-derived GM-CSF promotes inflammatory colon carcinogenesis via stimulating epithelial release of VEGF. Cancer Res 2014; 74:716-26; PMID:24366884; http://dx.doi.org/10.1158/0008-5472.CAN-13-1459